A Survey of Medical Oncologist’s Opinions and Perceptions Regarding the Management of Dermatologic Toxicities among mCRC Patients Treated with Vectibix (20160258)

26/04/2017
02/07/2024
EU PAS number:
EUPAS18060
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Study results
Study results

20160258_ORSR Final_Abstract

English (74.49 KB - PDF) View document
Study report
Other information